| Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register AA Saad, DM Ashcroft, KD Watson, KL Hyrich, PR Noyce, DPM Symmons, ... Arthritis research & therapy 11, 1-9, 2009 | 231 | 2009 |
| Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials. AA Saad, DPM Symmons, PR Noyce, DM Ashcroft The Journal of rheumatology 35 (5), 883-890, 2008 | 178 | 2008 |
| Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register AA Saad, DM Ashcroft, KD Watson, DPM Symmons, PR Noyce, KL Hyrich Rheumatology 49 (4), 697-705, 2010 | 167 | 2010 |
| Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register AA Saad, DM Ashcroft, KD Watson, DPM Symmons, PR Noyce, KL Hyrich Rheumatology 49 (4), 697-705, 2010 | 165 | 2010 |
| Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies AA Saad, DM Ashcroft, KD Watson, DPM Symmons, PR Noyce, KL Hyrich, ... Arthritis care & research 62 (3), 345-353, 2010 | 53 | 2010 |
| Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies AA Saad, DM Ashcroft, KD Watson, DPM Symmons, PR Noyce, KL Hyrich, ... Arthritis care & research 62 (3), 345-353, 2010 | 53 | 2010 |
| Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis AA Saad, KL Hyrich, DM Ashcroft Expert opinion on drug safety 10 (2), 219-226, 2011 | 13 | 2011 |
| Efficacy of PSB with phosphatic fertilizers on the yield of chickpea grown on calcareous soil of north Bihar. AA Saad, HM Sharma | 10 | 2003 |
| British Society for Rheumatology Biologics Register Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the … AA Saad, DM Ashcroft, KD Watson, KL Hyrich, PR Noyce, DP Symmons Arthritis Res Ther 11 (2), R52, 2009 | 9 | 2009 |
| Improvements in Quality of Life and Functional Status in Patients with Psoriatic Arthritis Receiving Anti-TNF Therapies: Analysis of the BSR Biologics Register (BSRBR) AA Saad, DM Ashcroft, KD Watson, DP Symmons, KL Hyrich PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 18, S258-S258, 2009 | 1 | 2009 |
| Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies KD Watson, AA Saad, DM Ashcroft | | 2010 |
| Improvements in quality of life and functional status in patients with psoriatic arthritis: Analysis of the BSR Biologics Register AA Saad, DM Ashcroft, KD Watson, DP Symmons, KL Hyrich 25th International Conference on Pharmacoepidemiology and Risk Management, S258, 2009 | | 2009 |
| Clinical evaluation of the risk-benefit profile of biological therapies in the management of psoriatic arthritis AAMAR Saad PQDT-Global, 2009 | | 2009 |
| Drug persistence on anti-TNF-a agents in psoriatic arthritis AA Saad, DM Ashcroft, KD Watson, KL Hyrich, PR Noyce Pharmacoepidemiology and Drug Safety, 2008 | | 2008 |
| Efficacy and safety of anti-TNF agents in psoriatic arthritis: Results from the BSR biologics register A Saad, DM Ashcroft, KD Watson, KL Hyrich, PR Noyce, D Symmons Rheumatology, 2008 | | 2008 |
| Risks and Benefits of TNF-alpha Inhibitors in the Management of PsA: Systematic Review and Metaanalysis of Randomized Controlled Trials AA Saad, DPM Symmons, PR Noyce, DM Ashcroft JOURNAL OF RHEUMATOLOGY 35 (5), 883, 2008 | | 2008 |
| Using Bayesian methods in evidence synthesis: Examining the risk-benefit ratio of TNF inhibitors with direct and indirect comparisons AA Saad, PR Noyce, CEM Griffiths, DM Ashcroft International Journal Of Pharmacy Practice, 2007 | | 2007 |
| Meta-analysis of the efficacy and safety of TNF-alpha inhibitors in the management of psoriatic arthritis AA Saad, DM Ashcroft, D Symmons, PR Noyce Rheumatology, 2007 | | 2007 |
| Risk-benefit of new biologicals in the treatment of chronic plaque psoriasis AA Saad, DM Ashcroft, CEM Griffiths, PR Noyce International Journal Of Pharmacy Practice, 2006 | | 2006 |
| Spondylarthropathies (Including Psoriatic Arthritis) AA Saad, DM Ashcroft, DPM Symmons, PR Noyce, CE Unit | | |
